Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-22-003371

Options or other derivatives

  • CEO acquired 240,448 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Fried Robert N CEO 2022-02-17 Grant or award · Employee Stock Options (right to buy) +240,448 240,448 D: show line 1 in the form
Loading xslF345X03/wf-form4_164556891215777.xml…